Status:
COMPLETED
Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
There is substantial, continuing, and unexplained rise in prescribing of proton pump inhibitors. It is unknown whether their use in practice has corresponded to their licensed indications. Although t...
Detailed Description
Dyspeptic symptoms are a common presenting complaint, and there is continuing debate about management. Acid suppressant drugs, the most potent of which are proton pump inhibitors, are often prescribed...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ischemic Heart Disease
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
End Date :
November 1 2006
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00392964
Start Date
January 1 2006
End Date
November 1 2006
Last Update
April 11 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam: Health Care Campus
Haifa, Israel, 31096
2
Rambam Health Care Campus
Haifa, Israel